Where Clinical Data, Science & Evidence Transforms Women’s Health
This stage explores the impact of internal and external stigma on sexual health and its role in shaping access, awareness, and patient outcomes. It highlights the importance of open dialogue and education to break down barriers and encourage more inclusive, informed care. The stage also examines innovative manufacturing pathways that move beyond conventional regulatory approaches to accelerate progress in sexual health solutions. Discover how these advancements are driving a more progressive, accessible, and responsive sexual health landscape.
Register Now
Explore Innovative Product Manufacturing Pathways Beyond Conventional Regulatory Models
Daré Bioscience
Provide Improved Sexual Health Care by Understanding Patient and Clinician Barriers
Mayo Clinic
The Clinical Impact of Internal Stigma in Sexual Health
Gilead
Who Should Attend
- Pharma & Biotech pipeline scouting and sexual health innovation teams
- Clinical researchers and medical affairs professionals
- Clinicians focused on women’s sexual health outcomes
- Policy and public health leaders addressing stigma and access
Key Topics
Focus: Prevention, access, stigma reduction, and patient-centered care
- Expanding access to sexual health services and contraception
- Personalized approaches to sexual health prevention and screening
- STI and STD prevention through earlier intervention
- Understanding patient and clinician barriers to care
- Sexual health infrastructure, digital care, and regulatory compliance
- Reducing stigma and improving patient engagement
- Cancer survivorship and long-term sexual health outcomes
We believe in equitable healthcare. That is why attendance is free for any medical officers and leaders within hospitals and healthcare systems, pharma, biotech, corporate enterprises and government officials.
See Our Cognitive Health & Wellness Stage
